HIF1A and myelodysplastic syndrome: Based on these results, it is presumed that, in MDS patients, HIF‐1α will bind to miR‐93‐5p by targeting and participate in angiogenesis in the bone marrow, thereby fulfilling its biological functions in the initiation and progression of MDS.